December 26, 2011


Lohmann Animal Health acquires Immuno-Vet Services CC (Press Release)



With the aim to strengthen its market position on the African continent, especially to expand even more actively into the sub-Saharan regions, Lohmann Animal Health GmbH & Co. KG has acquired its former distributor, Immuno-Vet Services CC in Johannesburg, South Africa.


At the end of November, the co-founder and previous principal owner of Immuno-Vet, Harry Mahieu jointly signed the acquisition contract of the South African company, which had been established in the mid-1980s, together with Lohmann's Managing Director Dr. Bruno Kaesler and Messrs. Dean Hewson and Wanda Viljoen. Currently, an integration process for the more than 50 employees is implemented on site. This  allows them to become acquainted with the corporate structure and process world of Lohmann Animal Health in time and before the closing is expected to take place in February 2012 and general business operations are about to start.


Immuno-Vet is to keep its individual business profile, which is why Lohmann continues to be represented by the already established local company Lohmann Animal Health SA (Pty) Ltd. Both companies will co-exist as independent economic players in order to ensure that the widest possible portfolio of vaccines and feed additives can be marketed successfully and thus the maximum impact in the market can be achieved by the new subsidiary.


Thierry Vendrell, Sales Director for the regions of Southern Europe and Africa at Lohmann Animal Health GmbH & Co. KG as well as Head of the acquisition project says, "With the new subsidiary, we provide a central hub for our business activities in southern Africa. Lohmann Animal Health strengthens its presence in Africa and may expand the existing market share, not least by means of using the already established distribution and sales structures. Our customers benefit from faster service times and a broadening of our product portfolio, thanks to the Immuno-Vet Services range of products."

Video >

Follow Us